title: The intravascular contrast agent Clariscan (NC 100150 injection) for 3D MR coronary angiography in patients with coronary artery disease.
authors.affiliation: Internal Medicine Cardiology, Charité, Humboldt University, Berlin, Germany. c.klein@lrz.tu-muenchen.de
authors.forename: C
authors.initials: C
authors.lastname: Klein
authors.forename: E
authors.initials: E
authors.lastname: Nagel
authors.forename: B
authors.initials: B
authors.lastname: Schnackenburg
authors.forename: A
authors.initials: A
authors.lastname: Bornstedt
authors.forename: S
authors.initials: S
authors.lastname: Schalla
authors.forename: V
authors.initials: V
authors.lastname: Hoffmann
authors.forename: A
authors.initials: A
authors.lastname: Lehning
authors.forename: E
authors.initials: E
authors.lastname: Fleck
mesh_terms: D003287:Contrast Media; D003327:Coronary Disease / Q000175:diagnosis*; D003911:Dextrans; D052203:Ferrosoferric Oxide; D006801:Humans; D007091:Image Processing, Computer-Assisted / Q000379:methods; D007501:Iron; D018810:Magnetic Resonance Angiography / Q000379:methods*; D058185:Magnetite Nanoparticles; D010087:Oxides
chemical_list: D003287:Contrast Media; D003911:Dextrans; D058185:Magnetite Nanoparticles; D010087:Oxides; C097921:ferumoxtran-10; D007501:Iron; D052203:Ferrosoferric Oxide